Kidney stone disease is a crystal concretion formed in the kidneys that has been associated with an increased risk of
chronic kidney disease.
MicroRNAs are functionally involved in kidney injury. Data mining using a
microRNA array database suggested that miR-21 may be associated with
calcium oxalate monohydrate (COM)-induced renal tubular cell injury. Here, we confirmed that COM exposure significantly upregulated miR-21 expression, inhibited proliferation, promoted apoptosis, and caused
lipid accumulation in an immortalized renal tubular cell line (HK-2). Moreover, inhibition of miR-21 enhanced proliferation and decreased apoptosis and
lipid accumulation in HK-2 cells upon COM exposure. In a
glyoxylate-induced mouse model of renal
calcium oxalate deposition, increased miR-21 expression,
lipid accumulation, and kidney injury were also observed. In silico analysis and subsequent experimental validation confirmed the
peroxisome proliferator-activated receptor (
PPAR)-α gene (PPARA) a key gene in
fatty acid oxidation, as a direct miR-21 target. Suppression of miR-21 by
miRNA antagomiR or activation of
PPAR-α by its selective agonist
fenofibrate significantly reduced renal
lipid accumulation and protected against renal injury in vivo. In addition, miR-21 was significantly increased in urine samples from patients with
calcium oxalate renal stones compared with healthy volunteers. In situ hybridization of biopsy samples from patients with
nephrocalcinosis revealed that miR-21 was also significantly upregulated compared with normal kidney tissues from patients with
renal cell carcinoma who underwent radical
nephrectomy. These results suggested that miR-21 promoted
calcium oxalate-induced renal tubular cell injury by targeting PPARA, indicating that miR-21 could be a potential therapeutic target and
biomarker for
nephrolithiasis.